发明授权
US08815237B2 Aglycosylated immunoglobulin mutants 有权
糖基化免疫球蛋白突变体

Aglycosylated immunoglobulin mutants
摘要:
The present invention is based, in part, on our discovery of immunoglobulins (e.g., immunoglobulin G (IgG)) polypeptides (e.g., murine or human IgG, such as human IgG1) that are aglycosylated yet retain the ability to bind to an Fc receptor, such as an activating Fc receptor (e.g., FcγRIIA and/or FcγRIIIA).
公开/授权文献
信息查询
0/0